January 4, 2007
View Full PaperDopamine Agonists and the Risk of Cardiac-Valve Regurgitation
Key Points
Key points are not available for this paper at this time.
Abstract
In this study, use of the dopamine agonists pergolide and cabergoline was associated with an increased risk of newly diagnosed cardiac-valve regurgitation.